337-29391-73687
5 vaccinations
3 coded responses
51 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
H3J-88258-83964
Child or adolescent in my care · Male · 2022-07-03
Timeline
-
2021-03-20
Registered in v-safe
-
2021-03-20
Dose 1 — Moderna
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-10
-
2021-04-20
Dose 2 — Moderna
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, DiarrheaAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
- 2021-10-19
-
2021-12-04
Dose 3 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-07
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-03
- 2022-01-08
- 2022-01-15
- 2022-03-05
- 2022-06-04
-
2022-07-02
Dose 4 — Moderna
- 2022-07-03
- 2022-07-04
- 2022-07-05
-
2022-07-17
Survey response — day 14, dose 4MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend schoolFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-23
Survey response — day 21, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Bad cold and tested positive for CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-07-30
- 2022-08-06
- 2022-10-01
-
2022-12-17
Dose 5 — ModernaCo-administered: Flu
- 2022-12-31
- 2022-12-31
-
2023-01-07
Survey response — day 21, dose 5MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-01-14
- 2023-01-21
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Moderna | |
| 2 | 2021-04-20 | Moderna | |
| 3 | 2021-12-04 | Pfizer-BioNTech | No |
| 4 | 2022-07-02 | Moderna | No |
| 5 | 2022-12-17 | Moderna | Flu |
Free text
Release 12 — day 14, dose 4
Symptoms: Cold symptoms
Release 12 — day 21, dose 4
Symptoms: Bad cold and tested positive for Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release